CoChat
Cited by 37

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons

Haukedal, Henriette, Corsi, Giulia I., Gadekar, Veerendra P., Doncheva, Nadezhda T., Kedia, Shekhar, de Haan, Noortje, Chandrasekaran, Abinaya, Jensen, Pia, Schiønning, Pernille, Vallin, Sarah, Marlet, Frederik Ravnkilde, Poon, Anna, Pires, Carlota, Agha, Fawzi Khoder, Wandall, Hans H., Cirera, Susanna, Simonsen, Anja Hviid, Nielsen, Troels Tolstrup, Nielsen, Jørgen Erik, Hyttel, Poul, Muddashetty, Ravi, Aldana, Blanca I., Gorodkin, Jan, Nair, Deepak, Meyer, Morten, Larsen, Martin Røssel, Freude, Kristine · 2023 · Frontiers in Neuroscience

Published version of a preprint

Abstract

Alzheimer’s disease (AD) is the most common cause of dementia, with no current cure. Consequently, alternative approaches focusing on early pathological events in specific neuronal populations, besides targeting the well-studied amyloid beta (Aβ) accumulations and Tau tangles, are needed. In this study, we have investigated disease phenotypes specific to glutamatergic forebrain neurons and mapped the timeline of their occurrence, by implementing familial and sporadic human induced pluripotent stem cell models as well as the 5xFAD mouse model. We recapitulated characteristic late AD phenotypes, such as increased Aβ secretion and Tau hyperphosphorylation, as well as previously well documented mitochondrial and synaptic deficits. Intriguingly, we identified Golgi fragmentation as one of the earliest AD phenotypes, indicating potential impairments in protein processing and post-translational modifications. Computational analysis of RNA sequencing data revealed differentially expressed genes involved in glycosylation and glycan patterns, whilst total glycan profiling revealed minor glycosylation differences. This indicates general robustness of glycosylation besides the observed fragmented morphology. Importantly, we identified that genetic variants in Sortilin-related receptor 1 ( SORL1 ) associated with AD could aggravate the Golgi fragmentation and subsequent glycosylation changes. In summary, we identified Golgi fragmentation as one of the earliest disease phenotypes in AD neurons in various in vivo and in vitro complementary disease models, which can be exacerbated via additional risk variants in SORL1 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2023.1120086

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Research works printed but not linked: 54

  1. Adams, 2020, Skyline for small molecules: a unifying software package for quantitative metabolomics., J. Proteome Res., 19, 1447, 10.1021/ACS.JPROTEOME.9B00640 · DOI · Paper page
  2. Afzal, 2021, Effect of crista morphology on mitochondrial ATP output: a computational study., Curr. Res. Physiol., 4, 163, 10.1016/J.CRPHYS.2021.03.005 · DOI
  3. 2022, More than normal aging: understanding mild cognitive impairment., Alzheimers Dement., 18, 545
  4. Andersen, 2005, Neuronal sorting protein-related receptor SorLA/LR11 regulates processing of the amyloid precursor protein., Proc. Natl. Acad. Sci. U.S.A., 102, 10.1073/PNAS.0503689102 · DOI · Paper page
  5. Antón-Fernández, 2017, Morphometric alterations of golgi apparatus in Alzheimer’s disease are related to tau hyperphosphorylation., Neurobiol. Dis., 97, 10.1016/J.NBD.2016.10.005 · DOI
  6. Balaban, 2005, Mitochondria, oxidants, and aging., Cell, 120, 483, 10.1016/J.CELL.2005.02.001 · DOI · Paper page
  7. Baloyannis, 2014, Golgi apparatus and protein trafficking in Alzheimer’s disease., J. Alzheimers Dis., 42, S153, 10.3233/JAD-132660 · DOI
  8. Berchtold, 2014, Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer’s disease., Neurobiol. Aging, 35, 1961, 10.1016/J.NEUROBIOLAGING.2014.03.031 · DOI · Paper page
  9. Cai, 2003, Presenilin-1 regulates intracellular trafficking and cell surface delivery of β-amyloid precursor protein., J. Biol. Chem., 278, 3446, 10.1074/jbc.M209065200 · DOI · Paper page
  10. Corsi, CRISPRroots: on- and off-target assessment of RNA-Seq data in CRISPR–Cas9 edited cells., Nucleic Acids Res., 50, 10.1093/NAR/GKAB1131 · DOI
  11. Corsi, The transcriptomic landscape of neurons carrying PSEN1 mutations reveals changes in extracellular matrix components and non-coding gene expression., Neurobiol. Dis., 178, 10.1016/J.NBD.2022.105980 · DOI
  12. Damerell, 2012, The glycanbuilder and glycoworkbench glycoinformatics tools: updates and new developments., Biol. Chem., 393, 1357, 10.1515/HSZ-2012-0135 · DOI · Paper page
  13. de Haan, 2022, In-depth profiling of O-glycan isomers in human cells using C18 nanoliquid chromatography–mass spectrometry and glycogenomics., Analyt. Chem., 94, 4343, 10.1021/ACS.ANALCHEM.1C05068 · DOI
  14. Dobin, 2013, STAR: ultrafast universal RNA-Seq aligner., Bioinformatics, 29, 15, 10.1093/BIOINFORMATICS/BTS635 · DOI · Paper page
  15. Fjorback, 2012, Retromer binds the FANSHY sorting motif in SorLA to regulate amyloid precursor protein sorting and processing., J. Neurosci., 32, 1467, 10.1523/JNEUROSCI.2272-11.2012 · DOI · Paper page
  16. Frankish, 2019, GENCODE reference annotation for the human and mouse genomes., Nucleic Acids Res., 47, D766, 10.1093/NAR/GKY955 · DOI · Paper page
  17. Frederiksen, 2019, Generation of two IPSC lines with either a heterozygous V717I or a heterozygous KM670/671NL mutation in the APP gene., Stem Cell Res., 34, 10.1016/J.SCR.2018.101368 · DOI
  18. García-Escudero, 2013, Deconstructing mitochondrial dysfunction in Alzheimer disease., Oxid. Med. Cell. Longev., 2013, 10.1155/2013/162152 · DOI
  19. Ikeuchi, 2010, Increased levels of soluble LR11 in cerebrospinal fluid of patients with Alzheimer disease., Dement. Geriatr. Cogn. Disord., 30, 28, 10.1159/000315539 · DOI
  20. Joshi, 2015, Golgi fragmentation in Alzheimer’s disease., Front. Neurosci., 9, 10.3389/FNINS.2015.00340 · DOI
  21. Joshi, 2014, Aβ-induced golgi fragmentation in Alzheimer’s disease enhances Aβ production., Proc. Natl. Acad. Sci. U.S.A., 111, E1230, 10.1073/pnas.1320192111 · DOI · Paper page
  22. Kedia, 2020, Real-time nanoscale organization of amyloid precursor protein., Nanoscale, 12, 8200, 10.1039/D0NR00052C · DOI
  23. Kedia, 2021, Alteration in synaptic nanoscale organization dictates amyloidogenic processing in Alzheimer’s disease., IScience, 24, 10.1016/j.isci.2020.101924 · DOI
  24. Kizuka, 2017, N-Glycan and Alzheimer’s disease., Biochim. Biophys. Acta Gen. Subj., 1861, 2447, 10.1016/j.bbagen.2017.04.012 · DOI
  25. Kizuka, 2016, Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions., Biochem. J., 473, 21, 10.1042/BJ20150607 · DOI · Paper page
  26. Kumar-Singh, 2006, Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased abeta 42 and decreased abeta 40., Hum. Mutat., 27, 686, 10.1002/humu · doi:10.1002/humu
  27. Lageveen-Kammeijer, 2019, Highly sensitive CE-ESI-MS analysis of N-glycans from complex biological samples., Nat. Commun., 10, 10.1038/S41467-019-09910-7 · DOI
  28. Li, 2019, Golgi structure and function in health, stress, and diseases., Results Probl. Cell Diff., 67, 441, 10.1007/978-3-030-23173-6_19/TABLES/2 · doi:10.1007/978-3-030-23173-6_19/tables/2
  29. Li, 2016, Generation of induced pluripotent stem cells (IPSCs) from an Alzheimer’s disease patient carrying an A79V mutation in PSEN1., Stem Cell Res., 16, 229, 10.1016/j.scr.2016.01.002 · DOI
  30. Liao, 2014, FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features., Bioinformatics, 30, 923, 10.1093/BIOINFORMATICS/BTT656 · DOI · Paper page
  31. Louwersheimer, 2017, Rare genetic variant in SORL1 may increase penetrance of Alzheimer’s disease in a family with several generations of APOE-ε4 homozygosity., J. Alzheimers Dis., 56, 63, 10.3233/JAD-160091 · DOI
  32. Marsh, 2018, Synaptic dysfunction in Alzheimer’s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention., Neural Regener. Res., 13, 616, 10.4103/1673-5374.230276 · DOI
  33. Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads., EMBnet J., 17, 10, 10.14806/EJ.17.1.200 · DOI · Paper page
  34. Martínez-Menárguez, 2019, Golgi fragmentation in neurodegenerative diseases: is there a common cause?, Cells, 8, 10.3390/CELLS8070748 · DOI
  35. Metaxas, 2016, Neurofibrillary tangles in Alzheimer’s disease: elucidation of the molecular mechanism by immunohistochemistry and tau protein phospho-proteomics., Neural Regener. Res., 11, 1579, 10.4103/1673-5374.193234 · DOI · Paper page
  36. Peng, 2021, Identification of SCARA3 with potential roles in metabolic disorders., Aging, 13, 10.18632/AGING.202228 · DOI
  37. Pires, 2016, Generation of a gene-corrected isogenic control cell line from an Alzheimer’s disease patient IPSC line carrying a A79V mutation in PSEN1., Stem Cell Res., 17, 285, 10.1016/j.scr.2016.08.002 · doi:10.1016/j.scr.2016.08.002
  38. Pool, 2008, NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth., J. Neurosci. Methods, 168, 134, 10.1016/J.JNEUMETH.2007.08.029 · DOI · Paper page
  39. Poon, 2016, Generation of a gene-corrected isogenic control HiPSC line derived from a familial Alzheimer’s disease patient carrying a L150P mutation in presenilin 1., Stem Cell Res., 17, 466, 10.1016/j.scr.2016.09.018 · doi:10.1016/j.scr.2016.09.018
  40. Quast, 2013, The SILVA ribosomal RNA gene database project: improved data processing and web-based tools., Nucleic Acids Res., 41, 10.1093/NAR/GKS1219 · DOI · Paper page
  41. Rasmussen, 2014, Transient P53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage., Stem Cell Rep., 3, 404, 10.1016/J.STEMCR.2014.07.006/ATTACHMENT/55CA1981-94D7-441F-B860-5D6D63F62061/MMC1.PDF · doi:10.1016/j.stemcr.2014.07.006/attachment/55ca1981-94d7-441f-b860-5d6d63f62061/mmc1.pdf
  42. Reynolds, 1963, The use of lead citrate at a high pH as an electron opaque stain in electron microscopy, J. Cell Biol, 17, 208, 10.1083/jcb.17.1.208 · DOI · Paper page
  43. Schlattner, 2006, Mitochondrial creatine kinase in human health and disease., Biochim. Biophys. Acta, 1762, 164, 10.1016/J.BBADIS.2005.09.004 · DOI · Paper page
  44. Selkoe, 2016, The amyloid hypothesis of Alzheimer’s disease at 25 years., EMBO Mol. Med., 8, 595, 10.15252/EMMM.201606210 · DOI · Paper page
  45. Selman, 2011, Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides., Anal. Chem., 83, 2492, 10.1021/AC1027116 · DOI · Paper page
  46. Shi, 2012, Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks., Nat. Protoc., 7, 1836, 10.1038/nprot.2012.116 · DOI · Paper page
  47. Sun, 2017, Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase., Proc. Natl. Acad. Sci. U.S.A., 114, E476, 10.1073/pnas.1618657114 · DOI · Paper page
  48. Tan, 2019, The trans-golgi network is a major site for α-secretase processing of amyloid precursor protein in primary neurons., J. Biol. Chem., 294, 10.1074/JBC.RA118.005222 · DOI · Paper page
  49. Tubsuwan, 2016, Generation of induced pluripotent stem cells (IPSCs) from an Alzheimer’s disease patient carrying a L150P mutation in PSEN-1., Stem Cell Res., 16, 110, 10.1016/j.scr.2015.12.015 · DOI
  50. Velasco, 1993, Cell type-dependent variations in the subcellular distribution of alpha- mannosidase I and II., J. Cell Biol., 122, 39, 10.1083/JCB.122.1.39 · DOI · Paper page
  51. Wang, 2012, RSeQC: quality control of RNA-Seq experiments., Bioinformatics, 28, 2184, 10.1093/BIOINFORMATICS/BTS35 · doi:10.1093/bioinformatics/bts35
  52. Ye, 2005, Apolipoprotein (Apo) E4 enhances amyloid beta peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target., Proc. Natl. Acad. Sci. U.S.A., 102, 18700, 10.1073/PNAS.0508693102 · DOI · Paper page
  53. Yu, 2012, Synapses and dendritic spines as pathogenic targets in Alzheimer’s disease., Neural Plast., 2012, 10.1155/2012/247150 · DOI
  54. Zollo, 2017, Sortilin-related receptor expression in human neural stem cells derived from Alzheimer’s disease patients carrying the APOE epsilon 4 allele., Neural Plast., 2017, 10.1155/2017/1892612 · DOI

Cited by

See all 37

Metadata

Authors
Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., Marlet, F. R., Poon, A., Pires, C., Agha, F. K., Wandall, H. H., Cirera, S., Simonsen, A. H., Nielsen, T. T., Nielsen, J. E., Hyttel, P., Muddashetty, R., Aldana, B. I., Gorodkin, J., Nair, D., Meyer, M., Larsen, M. R., & Freude, K.
Venue
Frontiers in Neuroscience
Published
2023-02-16
Volume
17
ISSN
1662-453X
Cited by
37
References
22
Funders
  • Innovationsfonden (4108-00008B, 4096-00001B)
  • Novo Nordisk Fonden (NNF1818OC0052369, NNF21OC0071571, NNF14CC0001)
  • Lundbeckfonden (R313-2019-869)
  • European Research Council (GlycoSkin H2020-ERC; 772735)
  • European Commission (Remodel)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons. https://app.cochat.ai/papers/10.3389/fnins.2023.1120086
The paper
Haukedal, H., Corsi, G. I., Gadekar, V. P., Doncheva, N. T., Kedia, S., de Haan, N., Chandrasekaran, A., Jensen, P., Schiønning, P., Vallin, S., Marlet, F. R., Poon, A., Pires, C., Agha, F. K., Wandall, H. H., Cirera, S., Simonsen, A. H., Nielsen, T. T., Nielsen, J. E., . . . Freude, K. (2023). Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neurons. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2023.1120086

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.